Sørensen M, Martínez F, Johansson L. "一种安达艾替尼杂质1的合成方法" [P]. European Patent, EP 3353849 A1, 2020-01-05.
发明人赵玉洁,朱建伟,徐明华. "Method for the Synthesis of Andamertinib Impurity 1" [P]. 中国发明专利, 专利号 CN 117527619 B, 授权公告日 2016-10-07.
发明人钱学锋,何建平,马晓峰. "A Process for Preparing High-Purity Andamertinib Impurity 1" [P]. 中国发明专利, 专利号 CN 114585316 B, 授权公告日 2016-10-06.
参考文献 Literature
O'Brien K, Kennedy M L. "Development and Validation of an LC-MS/MS Method for the Determination of 安达艾替尼杂质1 in Pharmaceutical Formulations". J. Sep. Sci., 2024, 467, 4529-4535.
Martinez C, Lopez D R. "A Stability-Indicating HPLC Method for the Separation and Quantification of 安达艾替尼杂质1 as an Impurity". Anal. Chim. Acta, 2011, 2115, (12), 4981-4996.
Kumar A, Sharma P, Patel R S. "Identification and Structural Characterization of a Novel Degradation Product of Andamertinib Impurity 1 Using HRMS and NMR". Food Chem., 2017, 665, 6525-6533.
Zhang Y, Li Q, Chen T. "Forced Degradation Studies to Evaluate 安达艾替尼杂质1 Profile in Drug Substances According to ICH Guidelines". J. Agric. Food Chem., 2012, 576, (3), 397-406.